346 related articles for article (PubMed ID: 18854656)
21. Systemic treatment of hepatocellular carcinoma: dawn of a new era?
Zhu AX
Ann Surg Oncol; 2010 May; 17(5):1247-56. PubMed ID: 20405329
[TBL] [Abstract][Full Text] [Related]
22. Sorafenib for the treatment of unresectable hepatocellular carcinoma.
Kane RC; Farrell AT; Madabushi R; Booth B; Chattopadhyay S; Sridhara R; Justice R; Pazdur R
Oncologist; 2009 Jan; 14(1):95-100. PubMed ID: 19144678
[TBL] [Abstract][Full Text] [Related]
23. Treatment options for hepatocellular carcinoma.
Sandhu DS; Tharayil VS; Lai JP; Roberts LR
Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 in hepatocellular carcinoma.
Wu T
Cancer Treat Rev; 2006 Feb; 32(1):28-44. PubMed ID: 16337744
[TBL] [Abstract][Full Text] [Related]
25. Management of advanced hepatocellular carcinoma in the era of targeted therapy.
Yau T; Chan P; Epstein R; Poon RT
Liver Int; 2009 Jan; 29(1):10-7. PubMed ID: 19120940
[TBL] [Abstract][Full Text] [Related]
26. The present and the future landscape of treatment of advanced hepatocellular carcinoma.
Rimassa L; Santoro A
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S273-80. PubMed ID: 20547314
[TBL] [Abstract][Full Text] [Related]
27. Novel inhibitors in development for hepatocellular carcinoma.
Wörns MA; Galle PR
Expert Opin Investig Drugs; 2010 May; 19(5):615-29. PubMed ID: 20374038
[TBL] [Abstract][Full Text] [Related]
28. Systemic treatment in hepatocellular carcinoma; 'A small step for man...'.
Witjes CD; Verhoef C; Verheul HM; Eskens FA
Neth J Med; 2009 Mar; 67(3):86-90. PubMed ID: 19307678
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of hepatocellular carcinoma and molecular therapies.
Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
[TBL] [Abstract][Full Text] [Related]
30. Emerging targeted strategies in advanced hepatocellular carcinoma.
Finn RS
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine kinase inhibitors to treat liver cancer.
Huynh H
Expert Opin Emerg Drugs; 2010 Mar; 15(1):13-26. PubMed ID: 20128706
[TBL] [Abstract][Full Text] [Related]
32. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M
Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684
[TBL] [Abstract][Full Text] [Related]
33. Pathways and targets in hepatocellular carcinoma.
Psyrri A; Arkadopoulos N; Vassilakopoulou M; Smyrniotis V; Dimitriadis G
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1347-57. PubMed ID: 23176622
[TBL] [Abstract][Full Text] [Related]
34. Vascular changes in hepatocellular carcinoma.
Yang ZF; Poon RT
Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
[TBL] [Abstract][Full Text] [Related]
35. Molecularly targeted therapy for hepatocellular carcinoma.
Tanaka S; Arii S
Cancer Sci; 2009 Jan; 100(1):1-8. PubMed ID: 19038007
[TBL] [Abstract][Full Text] [Related]
36. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
Ramanathan RK; Belani CP; Singh DA; Tanaka M; Lenz HJ; Yen Y; Kindler HL; Iqbal S; Longmate J; Mack PC; Lurje G; Gandour-Edwards R; Dancey J; Gandara DR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):777-83. PubMed ID: 19169683
[TBL] [Abstract][Full Text] [Related]
37. Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma.
Cheng AL; Shen YC; Zhu AX
Oncology; 2011; 81(5-6):372-80. PubMed ID: 22269894
[TBL] [Abstract][Full Text] [Related]
38. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment.
Vilchez V; Turcios L; Marti F; Gedaly R
World J Gastroenterol; 2016 Jan; 22(2):823-32. PubMed ID: 26811628
[TBL] [Abstract][Full Text] [Related]
39. Targeted therapies for hepatocellular carcinoma.
Skelton MR; O'Neil B
Clin Adv Hematol Oncol; 2008 Mar; 6(3):209-18. PubMed ID: 18391920
[TBL] [Abstract][Full Text] [Related]
40. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
Zhu AX
Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
